INSIGHTS ON DRUG DEVELOPMENT
-
NanoImprove The Performance Of Your Formulations
Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.
-
5 Key Considerations For Companies Outsourcing Process Development
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
CRISPR Meets LNPs: A New Era In Cell And Gene Therapies
Explore how lipid nanoparticles are revolutionizing non-viral gene editing with scalable, efficient delivery for both ex vivo and in vivo applications, which features new CRISPR-LNP data in T cells.
-
Validation Provider Shortens The Path To Equipment Qualification
Explore the partnership enabling Transcat to meet regulatory requirements while focusing on core R&D and accelerating the delivery of life-changing therapies.
-
Quantification Of Exenatide Using Xevo TQD7/29/2025
Discover a highly sensitive and reliable LC-MS/MS method for quantifying exenatide in plasma that is powered by advanced sample prep and optimized column chemistries.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis8/27/2025
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More?3/17/2026
Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?
-
3 Key Considerations In Gene Therapy Manufacturing7/15/2025
Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.
-
5 Trends Impacting CMOs In 20252/4/2025
In 2025, CMOs will navigate Annex 1 compliance, the BioSecure Act’s uncertainty, AI-driven drug development, supply chain challenges from tariffs, and pandemic preparedness strategies.
DRUG DEVELOPMENT SOLUTIONS
-
Explore a system that has revolutionized analytical science and delivers faster throughput, sharper resolution, and reliable data to accelerate discovery and elevate your lab’s performance.
-
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
Optical microscope Leica DM2500 LED
Leica DM2500 LED optical microscopes are tools for demanding tasks in life science routine and research applications. With their transmitted light illumination, optical performance, and state-of-the-art accessories, they are especially well-suited for challenging life science research tasks that require differential interference contrast or high-performance fluorescence.
-
Explore how modern CMC approaches integrate advanced chemistry, scalable manufacturing, and strong analytics to streamline development, boost reliability, and sustain momentum to commercial supply.
-
See how modern flow-based manufacturing improves safety, consistency, and scalability through advanced reaction systems, real‑time analytics, and pilot-ready infrastructure.